Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 13,973
+170 (1.23%)
Mar 9, 2026, 5:00 PM SAST
Aspen Pharmacare Holdings Ratios and Metrics
Market cap in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 62,043 | 53,079 | 103,810 | 81,701 | 62,047 | 73,836 | Upgrade
|
| Market Cap Growth | -17.84% | -48.87% | 27.06% | 31.68% | -15.97% | 12.88% | Upgrade
|
| Enterprise Value | 89,366 | 81,746 | 128,328 | 100,452 | 81,357 | 101,518 | Upgrade
|
| Last Close Price | 139.73 | 116.89 | 224.02 | 172.83 | 127.83 | 147.38 | Upgrade
|
| PE Ratio | - | - | 23.57 | 15.63 | 9.56 | 15.36 | Upgrade
|
| Forward PE | 13.60 | 9.58 | 12.68 | 10.44 | 7.34 | 11.63 | Upgrade
|
| PS Ratio | 1.46 | 1.22 | 2.32 | 2.01 | 1.61 | 1.96 | Upgrade
|
| PB Ratio | 0.77 | 0.63 | 1.22 | 0.95 | 0.88 | 1.13 | Upgrade
|
| P/TBV Ratio | 1.84 | 3.71 | 7.46 | 4.45 | 4.68 | 9.88 | Upgrade
|
| P/FCF Ratio | 14.02 | 20.55 | 33.40 | 24.83 | 18.19 | 15.45 | Upgrade
|
| P/OCF Ratio | 8.95 | 10.29 | 16.68 | 14.80 | 11.55 | 10.82 | Upgrade
|
| PEG Ratio | 0.94 | 63.89 | 0.89 | 0.66 | 0.46 | 1.27 | Upgrade
|
| EV/Sales Ratio | 2.10 | 1.89 | 2.87 | 2.47 | 2.11 | 2.69 | Upgrade
|
| EV/EBITDA Ratio | 11.40 | 9.60 | 12.49 | 9.86 | 8.19 | 11.06 | Upgrade
|
| EV/EBIT Ratio | 14.79 | 11.69 | 14.47 | 11.25 | 9.31 | 12.52 | Upgrade
|
| EV/FCF Ratio | 20.20 | 31.65 | 41.29 | 30.53 | 23.85 | 21.24 | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.43 | 0.43 | 0.34 | 0.31 | 0.38 | Upgrade
|
| Debt / EBITDA Ratio | 4.20 | 4.13 | 3.47 | 2.82 | 2.20 | 2.66 | Upgrade
|
| Debt / FCF Ratio | 7.45 | 13.98 | 11.73 | 8.90 | 6.52 | 5.21 | Upgrade
|
| Net Debt / Equity Ratio | 0.34 | 0.35 | 0.28 | 0.21 | 0.23 | 0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.59 | 3.49 | 2.35 | 1.80 | 1.62 | 1.78 | Upgrade
|
| Net Debt / FCF Ratio | 6.18 | 11.50 | 7.76 | 5.58 | 4.71 | 3.42 | Upgrade
|
| Asset Turnover | 0.32 | 0.32 | 0.33 | 0.33 | 0.35 | 0.31 | Upgrade
|
| Inventory Turnover | 1.42 | 1.35 | 1.35 | 1.24 | 1.40 | 1.34 | Upgrade
|
| Quick Ratio | 1.03 | 1.17 | 1.06 | 1.06 | 0.79 | 0.52 | Upgrade
|
| Current Ratio | 3.64 | 2.21 | 1.81 | 1.92 | 1.48 | 0.89 | Upgrade
|
| Return on Equity (ROE) | -2.17% | -1.28% | 5.15% | 6.65% | 9.50% | 7.12% | Upgrade
|
| Return on Assets (ROA) | 2.85% | 3.18% | 4.06% | 4.54% | 4.94% | 4.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.57% | 6.26% | 6.40% | 7.43% | 8.25% | 6.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.40% | 5.90% | 7.70% | 8.00% | 9.90% | 11.10% | Upgrade
|
| Earnings Yield | -3.22% | -2.04% | 4.24% | 6.40% | 10.46% | 6.51% | Upgrade
|
| FCF Yield | 7.13% | 4.87% | 2.99% | 4.03% | 5.50% | 6.47% | Upgrade
|
| Dividend Yield | 1.53% | 1.80% | 1.60% | 1.98% | 2.55% | 1.78% | Upgrade
|
| Payout Ratio | - | - | 34.63% | 27.83% | 18.43% | - | Upgrade
|
| Buyback Yield / Dilution | -0.03% | 0.04% | - | 1.94% | 0.77% | - | Upgrade
|
| Total Shareholder Return | 1.49% | 1.85% | 1.60% | 3.92% | 3.32% | 1.78% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.